חזרה לתוצאות החיפוש

A Study of ASP2138 Given by Itself or Given With Other Cancer Treatments in Adults With Stomach Cancer, Gastroesophageal Junction Cancer, or Pancreatic Cancer

חו"ל (דורש נסיעה)מגייס משתתפיםPHASE1

מצבים רפואיים

Gastric Adenocarcinoma · Gastroesophageal Junction (GEJ) Adenocarcinoma · Pancreatic Adenocarcinoma

סיכום בשפה פשוטהבעזרת בינה מלאכותית

הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.

מיקומים

  • University of California Irvine Medical Center, Orange, California, United States

  • UCLA Dept of Medicine - Hematology/Oncology, Santa Monica, Santa Monica, California, United States

  • Northwestern University, Chicago, Illinois, United States

  • University of Kansas Cancer Center, Westwood, Kansas, United States

  • Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, United States

  • NYU Langone Medical Center - NYU Medical Oncology Associates, New York, New York, United States

  • Columbia University, New York, New York, United States

  • Memorial Sloan Kettering Cancer Center, New York, New York, United States

  • Duke Children's Hospital and Health Center, Durham, North Carolina, United States

  • Wake Forest University Baptist Health, Winston-Salem, North Carolina, United States

  • UT Southwestern Medical Center, Dallas, Texas, United States

  • Virginia Mason Medical Center, Seattle, Washington, United States

  • Froedtert Hospital and the Medical College of Wisconsin, Milwaukee, Wisconsin, United States

  • Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, China

  • Henan Cancer Hospital, Zhengzhou, Henan, China

  • Union Hospital affiliated to Tongji Medical College of Huazhong University of Science and Technology, Wuhan, Hubei, China

  • Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, Shanghai Municipality, China

  • The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, Zhejiang, China

  • Site FR33005, Vaillant, Villejuif, France

  • Site FR33003, Lyon, France

  • Site FR33004, Marseille, France

  • Site FR33006, Poitiers, France

  • Site FR33001, Saint-Herblain, France

  • Site FR33002, Toulouse, France

  • Site IT39004, Milan, Italy

  • Site IT39001, Milan, Italy

  • Site IT39005, Rozzano, Italy

  • Site IT39003, Verona, Italy

  • Aichi Cancer Center, Nagoya, Aichi-ken, Japan

  • National Cancer Center Hospital East, Kashiwa, Chiba, Japan

  • Kanagawa Cancer Center, Yokohama, Kanagawa, Japan

  • Kindai University Hospital, Sakai, Osaka, Japan

  • The University of Osaka Hospital, Suita, Osaka, Japan

  • National Cancer Center Hospital, Chuo-ku, Tokyo, Japan

  • The Cancer Institute Hospital of Japanese Foundation for Cancer Research, Koto-ku, Tokyo, Japan

  • PanOncology Trials, San Juan, Puerto Rico

  • Site KR82004, Seongnam-si, Gyeonggi-do, South Korea

  • Site KR82001, Guro-gu, Seoul, South Korea

  • Site KR82002, Jongno-gu, Seoul, South Korea

  • Site KR82003, Seocho-gu, Seoul, South Korea

  • Site KR82005, Seodaemun-gu, Seoul, South Korea

  • Site ES34001, Barcelona, Spain

  • Site ES34002, Barcelona, Spain

  • Site ES34006, Barcelona, Spain

  • Site ES34007, El Palmar, Spain

  • Site ES34004, Zaragoza, Spain

מובילי המחקר

  • Senior Director

    Study Director

    Astellas Pharma Global Development, Inc.

צפייה במקור ב־ClinicalTrials.gov(נפתח בחלון חדש)